Abbott's Alinity h-series system integrates a standalone hematology analyzer and slide maker-and-stainer module to enable high-throughput complete blood counting.
There were 58 M&A deals in the diagnostics space during the year, paced by Quest, which announced 12 deals. Abbott's $5.3 billion buy of Alere was the biggest acquisition.
Pacific Toxicology Laboratories has expanded its menu to include fentanyl and its analogues as deaths surge from synthetic opioid overdoses.
Siemens noted that in closing the acquisition of Epocal, the former Alere subsidiary, it has also completed its own blood gas portfolio.
The integrated instrument system runs clinical chemistry tests and immunoassays with a high throughput and small footprint.
A study found that the use of a blood test instead of urine decreased time to diagnosis and improved outcomes associated with missed pregnancy diagnoses.
Overall, the company reported its total revenues grew 29 percent year over year to $6.83 billion. It also said that it is reorganizing the Alere business, completed earlier this month.
The PCR-based test, run on Roche's Liat platform, was among several other assays that was cleared by the agency last month.
The company immediately borrowed $255 million to pay part of the $680 million price tag for Alere's MeterPro cardiovascular and toxicology business and its BNP assay business.